Fig. 3From: Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapyKaplan–Meier analysis for OS of patients in four subgroups: high–high group, high–low group, low–high group, low–low group (median survival, 29.3 months vs. 37.5 months vs. 55.2 months vs. 32 months, P < 0.05)Back to article page